Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma (Q46932503)

26 December 2017

title

Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma (English)

1 reference

26 December 2017

1 reference

H G Yang

1

1 reference

26 December 2017

B L Hu

series ordinal

2

1 reference

26 December 2017

L Xiao

series ordinal

3

1 reference

26 December 2017

P Wang

series ordinal

4

1 reference

26 December 2017

publication date

4 March 2011

1 reference

26 December 2017

published in

Cancer Gene Therapy

1 reference

26 December 2017

volume

18

1 reference

26 December 2017

page(s)

370-380

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/cgt.2011.13

exact match

0 references

cites work

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Regulation of T cell immunity by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Antigen presentation and T cell stimulation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

The use of dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Current developments in cancer vaccines and cellular immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Current state and perspectives of dendritic cell vaccination in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Targeting antigens to dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Engineering targeted viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Adenoviruses as vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34(+) cord blood-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Antigen presentation in retroviral vector-mediated gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Induction of therapeutic antitumor immunity by in vivo administration of a lentiviral vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Recombinant lentivector as a genetic immunization vehicle for antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Engineered lentivector targeting of dendritic cells for in vivo immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

An autologous oral DNA vaccine protects against murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Melanosomal targeting sequences from gp100 are essential for MHC class II-restricted endogenous epitope presentation and mobilization to endosomal compartments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Functional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Gene therapy meets vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

An essential role for Akt1 in dendritic cell function and tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

Dendritic cells in vivo: a key target for a new vaccine science

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

inferred from DOI database lookup

7 January 2021

based on heuristic

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

inferred from DOI database lookup

7 January 2021

based on heuristic

Binding of Sindbis virus to cell surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.13

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2011.13

1 reference

26 December 2017

PubMed ID

21372855

1 reference

26 December 2017